Literature DB >> 34046600

Structure-activity relationship studies on 2,5,6-trisubstituted benzimidazoles targeting Mtb-FtsZ as antitubercular agents.

Krupanandan Haranahalli1,2, Simon Tong2, Saerom Kim2, Monaf Awwa2, Lei Chen2, Susan E Knudson3, Richard A Slayden3, Eric Singleton4, Riccardo Russo4, Nancy Connell4,5, Iwao Ojima1,2.   

Abstract

Filamenting temperature sensitive protein Z (FtsZ) is an essential bacterial cell division protein and a promising target for the development of new antibacterial therapeutics. As a part of our ongoing SAR studies on 2,5,6-trisubstituted benzimidazoles as antitubercular agents targeting Mtb-FtsZ, a new library of compounds with modifications at the 2 position was designed, synthesized and evaluated for their activity against Mtb-H37Rv. This new library of trisubstituted benzimidazoles exhibited MIC values in the range of 0.004-50 μg mL-1. Compounds 6b, 6c, 20f and 20g showed excellent growth inhibitory activities ranging from 0.004-0.08 μg mL-1. This SAR study has led to the discovery of a remarkably potent compound 20g (MIC 0.0039 μg mL-1; normalized MIC 0.015 μg mL-1). Our 3DQSAR model predicted 20g as the most potent compound in the library. This journal is © The Royal Society of Chemistry.

Entities:  

Year:  2020        PMID: 34046600      PMCID: PMC8132993          DOI: 10.1039/d0md00256a

Source DB:  PubMed          Journal:  RSC Med Chem        ISSN: 2632-8682


  26 in total

1.  Effects of tubulin assembly inhibitors on cell division in prokaryotes in vivo.

Authors:  M Sarcina; C W Mullineaux
Journal:  FEMS Microbiol Lett       Date:  2000-10-01       Impact factor: 2.742

2.  Structure of Mycobacterium tuberculosis FtsZ reveals unexpected, G protein-like conformational switches.

Authors:  Adelaine K W Leung; E Lucile White; Larry J Ross; Robert C Reynolds; Joseph A DeVito; David W Borhani
Journal:  J Mol Biol       Date:  2004-09-17       Impact factor: 5.469

Review 3.  FtsZ and the division of prokaryotic cells and organelles.

Authors:  William Margolin
Journal:  Nat Rev Mol Cell Biol       Date:  2005-11       Impact factor: 94.444

Review 4.  Diverse paths to midcell: assembly of the bacterial cell division machinery.

Authors:  Nathan W Goehring; Jon Beckwith
Journal:  Curr Biol       Date:  2005-07-12       Impact factor: 10.834

5.  Microplate alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium.

Authors:  L Collins; S G Franzblau
Journal:  Antimicrob Agents Chemother       Date:  1997-05       Impact factor: 5.191

6.  Guanine nucleotide-dependent assembly of FtsZ into filaments.

Authors:  A Mukherjee; J Lutkenhaus
Journal:  J Bacteriol       Date:  1994-05       Impact factor: 3.490

7.  Design, synthesis and evaluation of novel 2,5,6-trisubstituted benzimidazoles targeting FtsZ as antitubercular agents.

Authors:  Bora Park; Divya Awasthi; Soumya R Chowdhury; Eduard H Melief; Kunal Kumar; Susan E Knudson; Richard A Slayden; Iwao Ojima
Journal:  Bioorg Med Chem       Date:  2014-04-01       Impact factor: 3.641

8.  Risk assessment of tuberculosis in immunocompromised patients. A TBNET study.

Authors:  Martina Sester; Frank van Leth; Judith Bruchfeld; Dragos Bumbacea; Daniela M Cirillo; Asli Gorek Dilektasli; José Domínguez; Raquel Duarte; Martin Ernst; Fusun Oner Eyuboglu; Irini Gerogianni; Enrico Girardi; Delia Goletti; Jean-Paul Janssens; Inger Julander; Berit Lange; Irene Latorre; Monica Losi; Roumiana Markova; Alberto Matteelli; Heather Milburn; Pernille Ravn; Theresia Scholman; Paola M Soccal; Marina Straub; Dirk Wagner; Timo Wolf; Aslihan Yalcin; Christoph Lange
Journal:  Am J Respir Crit Care Med       Date:  2014-11-15       Impact factor: 21.405

9.  pkCSM: Predicting Small-Molecule Pharmacokinetic and Toxicity Properties Using Graph-Based Signatures.

Authors:  Douglas E V Pires; Tom L Blundell; David B Ascher
Journal:  J Med Chem       Date:  2015-04-22       Impact factor: 7.446

Review 10.  Bedaquiline and delamanid in the treatment of multidrug-resistant tuberculosis: Promising but challenging.

Authors:  Yang Li; Feng Sun; Wenhong Zhang
Journal:  Drug Dev Res       Date:  2018-12-11       Impact factor: 4.360

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.